Riskpilot← Back to searchSign inGet full accessMabel Skincare Oy
OYActiveY-tunnus 2971584-3Erottajankatu 11-A20Other human health activities n.e.c. · NACE 8699Est. 20192 employeeswww.mabel.fi
Revenue 2025
EUR 949K
EBITDA margin
11.1%
Equity ratio
97.3%
Financial strength
Net profit 2025
EUR 52K
-74% vs 2024
| Revenue | EUR 949K | — |
| EBITDA | EUR 105K | — |
| Net profit | EUR 52K | -74% |
| Total assets | EUR 834K | +0% |
| Equity | EUR 811K | +0% |
| Employees | 2 | — |
Legal name
Mabel Skincare Oy
Y-tunnus number
2971584-3
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
24. tammikuuta 2019
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Muu terveyspalvelu. Kauneudenhoitopalvelut.
Address
Erottajankatu 11-A20
Website
www.mabel.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 425 | 635 | 743 | — | 949 |
| Staff expenses | −70 | −88 | −103 | −102 | −178 |
| EBITDA | 213 | 330 | 329 | — | 105 |
| Depreciation & amort. | −9 | −7 | −31 | −32 | −37 |
| EBIT | 204 | 323 | 297 | 252 | 69 |
| Net financials | −4 | −3 | −1 | — | −4 |
| Profit before tax | 200 | 320 | 297 | — | 65 |
| Tax | 40 | 64 | 60 | 50 | 13 |
| Net profit | 160 | 256 | 237 | 201 | 52 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 261 | 470 | 701 | 831 | 834 |
| Equity | 163 | 419 | 643 | 811 | 811 |
| Long-term debt | 61 | — | 0 | 0 | 0 |
| Short-term debt | 37 | 51 | 58 | 20 | 23 |
| Total debt | 98 | 51 | — | 20 | 23 |
EBITDA margin
11.1%
This company
15.8%
Market median
-30% vs market
20212025
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20212025
Return on equity
6.4%
This company
18.4%
Market median
-65% vs market
20212025
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20212025
Asset turnover
1.14×
This company
1.12×
Market median
+2% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
SM Deputy Member | Deputy Member | 2019 |
PJ | Audit | 2026 |
IE Chief Executive Officer | Chief Executive Officer | 2019 |
JK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mabel Skincare Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Solja Maria Suutarinen | Deputy Member | 0 companies |
| Perttu Johannes Mettomäki | Audit | 0 companies |
| Ida Emilia Ryhänen | Chief Executive Officer | 0 companies |
| Jenny Karoliina Mäki | Deputy Chief Executive Officer | 0 companies |